Legend Biotech shares jump nearly 61 percent in U.S. market debut - Reuters

GNNSF Stock  USD 1.25  0.01  0.79%   
Roughly 61% of Genscript Biotech's investor base is looking to short. The analysis of overall sentiment of trading Genscript Biotech pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Genscript Biotech's historical and current headlines, can help investors time the market. In addition, many technical investors use Genscript Biotech stock news signals to limit their universe of possible portfolio assets.
Genscript Biotech pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Genscript daily returns and investor perception about the current price of Genscript Biotech as well as its diversification or hedging effects on your existing portfolios.
  
Legend Biotech shares jump nearly 61 percent in U.S. market debut Reuters

Read at news.google.com
Google News at Macroaxis
  

Genscript Biotech Fundamental Analysis

We analyze Genscript Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Genscript Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Genscript Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Outstanding

Shares Outstanding Comparative Analysis

Genscript Biotech is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Genscript Biotech Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Genscript Biotech pink sheet to make a market-neutral strategy. Peer analysis of Genscript Biotech could also be used in its relative valuation, which is a method of valuing Genscript Biotech by comparing valuation metrics with similar companies.

Peers

Genscript Biotech Related Equities

ICCCImmuCell   6.03   
0%
50.0%
TLPPFTelix Pharmaceuticals   5.40   
0%
45.0%
MRUSMerus BV   3.33   
0%
28.0%
KROSKeros Therapeutics   2.17   
0%
18.0%
IVBXFInnovent Biologics   0.62   
0%
5.0%
NUVLNuvalent   0.05   
0%
1.0%
NUVBNuvation Bio   0.76   
6.0%
0%
INBXInhibrx   0.88   
7.0%
0%
NXTCNextCure   0.92   
7.0%
0%
ZNTLZentalis Pharmaceuticals   1.28   
10.0%
0%
LCTXLineage Cell   1.92   
16.0%
0%
KRONKronos Bio   2.00   
16.0%
0%
CNTBConnect Biopharma   2.61   
22.0%
0%
OVIDOvid Therapeutics   2.83   
23.0%
0%
CVKDCadrenal Therapeutics,   3.45   
29.0%
0%
CRNXCrinetics Pharmaceuticals   3.52   
29.0%
0%
ONTTFOxford Nanopore   3.92   
33.0%
0%
LYELLyell Immunopharma   11.84   
100.0%
0%

Complementary Tools for Genscript Pink Sheet analysis

When running Genscript Biotech's price analysis, check to measure Genscript Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genscript Biotech is operating at the current time. Most of Genscript Biotech's value examination focuses on studying past and present price action to predict the probability of Genscript Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genscript Biotech's price. Additionally, you may evaluate how the addition of Genscript Biotech to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
CEOs Directory
Screen CEOs from public companies around the world
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios